CN113801190A - 寡肽-1盐酸盐的制备方法 - Google Patents
寡肽-1盐酸盐的制备方法 Download PDFInfo
- Publication number
- CN113801190A CN113801190A CN202010536913.0A CN202010536913A CN113801190A CN 113801190 A CN113801190 A CN 113801190A CN 202010536913 A CN202010536913 A CN 202010536913A CN 113801190 A CN113801190 A CN 113801190A
- Authority
- CN
- China
- Prior art keywords
- boc
- peg
- lys
- fmoc
- trt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims abstract description 27
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 96
- 238000002360 preparation method Methods 0.000 claims abstract description 16
- 238000006243 chemical reaction Methods 0.000 claims description 70
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 60
- 238000003756 stirring Methods 0.000 claims description 42
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 24
- UMRUUWFGLGNQLI-QFIPXVFZSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CCCCNC(=O)OC(C)(C)C)C(O)=O)C3=CC=CC=C3C2=C1 UMRUUWFGLGNQLI-QFIPXVFZSA-N 0.000 claims description 21
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims description 19
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims description 19
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 claims description 19
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 16
- 239000011541 reaction mixture Substances 0.000 claims description 14
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims description 13
- 150000001413 amino acids Chemical class 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 12
- 229940126062 Compound A Drugs 0.000 claims description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 11
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 11
- XXMYDXUIZKNHDT-QNGWXLTQSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-(1-tritylimidazol-4-yl)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C(N=C1)=CN1C(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 XXMYDXUIZKNHDT-QNGWXLTQSA-N 0.000 claims description 9
- 230000001376 precipitating effect Effects 0.000 claims description 9
- VRPJIFMKZZEXLR-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid Chemical compound CC(C)(C)OC(=O)NCC(O)=O VRPJIFMKZZEXLR-UHFFFAOYSA-N 0.000 claims description 8
- 238000005859 coupling reaction Methods 0.000 claims description 8
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 claims description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- 230000008878 coupling Effects 0.000 claims description 6
- 238000010168 coupling process Methods 0.000 claims description 6
- FPIRBHDGWMWJEP-UHFFFAOYSA-N 1-hydroxy-7-azabenzotriazole Chemical compound C1=CN=C2N(O)N=NC2=C1 FPIRBHDGWMWJEP-UHFFFAOYSA-N 0.000 claims description 5
- 230000021736 acetylation Effects 0.000 claims description 5
- 238000006640 acetylation reaction Methods 0.000 claims description 5
- 239000006166 lysate Substances 0.000 claims description 5
- 239000012295 chemical reaction liquid Substances 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 239000007822 coupling agent Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- VVQIIIAZJXTLRE-QMMMGPOBSA-N (2s)-2-amino-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid Chemical compound CC(C)(C)OC(=O)NCCCC[C@H](N)C(O)=O VVQIIIAZJXTLRE-QMMMGPOBSA-N 0.000 claims description 3
- MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 claims description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims 2
- 239000007810 chemical reaction solvent Substances 0.000 abstract description 5
- 238000002474 experimental method Methods 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 4
- 230000007613 environmental effect Effects 0.000 abstract description 4
- 239000003960 organic solvent Substances 0.000 abstract description 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 3
- 229920001184 polypeptide Polymers 0.000 abstract description 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 40
- 239000000047 product Substances 0.000 description 24
- 239000012065 filter cake Substances 0.000 description 21
- 238000003786 synthesis reaction Methods 0.000 description 15
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 14
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical group CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 14
- 238000001914 filtration Methods 0.000 description 12
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 11
- 239000007791 liquid phase Substances 0.000 description 11
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- -1 iron ions Chemical class 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 5
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- YIWFXZNIBQBFHR-LURJTMIESA-N Gly-His Chemical compound [NH3+]CC(=O)N[C@H](C([O-])=O)CC1=CN=CN1 YIWFXZNIBQBFHR-LURJTMIESA-N 0.000 description 4
- 108010020688 glycylhistidine Proteins 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229910001431 copper ion Inorganic materials 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 238000010532 solid phase synthesis reaction Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000003746 solid phase reaction Methods 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 239000011345 viscous material Substances 0.000 description 2
- JFLSOKIMYBSASW-UHFFFAOYSA-N 1-chloro-2-[chloro(diphenyl)methyl]benzene Chemical compound ClC1=CC=CC=C1C(Cl)(C=1C=CC=CC=1)C1=CC=CC=C1 JFLSOKIMYBSASW-UHFFFAOYSA-N 0.000 description 1
- NDKDFTQNXLHCGO-UHFFFAOYSA-N 2-(9h-fluoren-9-ylmethoxycarbonylamino)acetic acid Chemical compound C1=CC=C2C(COC(=O)NCC(=O)O)C3=CC=CC=C3C2=C1 NDKDFTQNXLHCGO-UHFFFAOYSA-N 0.000 description 1
- MDMNSAVSQAHVLC-MDTVQASCSA-N 2-aminoacetic acid;(2s)-2-amino-3-(1h-imidazol-5-yl)propanoic acid;(2s)-2,6-diaminohexanoic acid Chemical group NCC(O)=O.NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CC1=CNC=N1 MDMNSAVSQAHVLC-MDTVQASCSA-N 0.000 description 1
- 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000013383 initial experiment Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000012716 precipitator Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- OHSJPLSEQNCRLW-UHFFFAOYSA-N triphenylmethyl radical Chemical compound C1=CC=CC=C1[C](C=1C=CC=CC=1)C1=CC=CC=C1 OHSJPLSEQNCRLW-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
缩写及英文 | 含义 |
HOAt | 1-羟基-7-偶氮苯并三氮唑 |
Fmoc | 9-芴甲氧羰基 |
HOBt | 1-羟基苯并三唑 |
EDC·HCl | 1-乙基-(3-二甲基氨基丙基)碳酰二亚胺盐酸盐 |
DMF | N,N-二甲基甲酰胺 |
DCM | 二氯甲烷 |
Boc | 叔丁氧羰基 |
His | 组氨酸 |
Gly | 甘氨酸 |
Lys | 赖氨酸 |
Trt | 三苯甲基 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010536913.0A CN113801190B (zh) | 2020-06-12 | 2020-06-12 | 寡肽-1盐酸盐的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010536913.0A CN113801190B (zh) | 2020-06-12 | 2020-06-12 | 寡肽-1盐酸盐的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113801190A true CN113801190A (zh) | 2021-12-17 |
CN113801190B CN113801190B (zh) | 2023-07-07 |
Family
ID=78892176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010536913.0A Active CN113801190B (zh) | 2020-06-12 | 2020-06-12 | 寡肽-1盐酸盐的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113801190B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116637209A (zh) * | 2023-05-18 | 2023-08-25 | 南京溯远基因科技有限公司 | 一种荧光染料复合物及其制备方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101155824A (zh) * | 2005-04-08 | 2008-04-02 | 隆萨股份公司 | 在PEG树脂上合成α-螺旋的肽合成法 |
CN103265629A (zh) * | 2013-05-28 | 2013-08-28 | 福建省闽东力捷迅药业有限公司 | 一种制备胸腺法新的固相合成新工艺 |
WO2019241586A1 (en) * | 2018-06-14 | 2019-12-19 | Cem Corporation | Solvent system for solid phase peptide synthesis |
CN111732649A (zh) * | 2020-08-04 | 2020-10-02 | 苏州金顶生物有限公司 | 连续流固相反应制备利拉鲁肽 |
CN112851930A (zh) * | 2020-08-04 | 2021-05-28 | 苏州金顶生物有限公司 | 一类用于多肽合成的含硫聚乙二醇树脂 |
CN112941132A (zh) * | 2021-05-17 | 2021-06-11 | 烟台市华昕生物医药科技有限公司 | 一种利用大肠杆菌表达寡肽-1的方法 |
CN113200919A (zh) * | 2021-05-19 | 2021-08-03 | 深圳瑞德林生物技术有限公司 | 一种n-乙酰-肌肽的合成方法 |
CN114057830A (zh) * | 2022-01-17 | 2022-02-18 | 浙江湃肽生物有限公司深圳分公司 | 寡肽-1衍生物及其制备方法和用途 |
-
2020
- 2020-06-12 CN CN202010536913.0A patent/CN113801190B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101155824A (zh) * | 2005-04-08 | 2008-04-02 | 隆萨股份公司 | 在PEG树脂上合成α-螺旋的肽合成法 |
CN103265629A (zh) * | 2013-05-28 | 2013-08-28 | 福建省闽东力捷迅药业有限公司 | 一种制备胸腺法新的固相合成新工艺 |
WO2019241586A1 (en) * | 2018-06-14 | 2019-12-19 | Cem Corporation | Solvent system for solid phase peptide synthesis |
CN111732649A (zh) * | 2020-08-04 | 2020-10-02 | 苏州金顶生物有限公司 | 连续流固相反应制备利拉鲁肽 |
CN112851930A (zh) * | 2020-08-04 | 2021-05-28 | 苏州金顶生物有限公司 | 一类用于多肽合成的含硫聚乙二醇树脂 |
CN112941132A (zh) * | 2021-05-17 | 2021-06-11 | 烟台市华昕生物医药科技有限公司 | 一种利用大肠杆菌表达寡肽-1的方法 |
CN113200919A (zh) * | 2021-05-19 | 2021-08-03 | 深圳瑞德林生物技术有限公司 | 一种n-乙酰-肌肽的合成方法 |
CN114057830A (zh) * | 2022-01-17 | 2022-02-18 | 浙江湃肽生物有限公司深圳分公司 | 寡肽-1衍生物及其制备方法和用途 |
Non-Patent Citations (3)
Title |
---|
LIAKOPOULOU-KYRIAKIDES 等: "A new synthesis of the tripeptide Gly-His-Lys with antimicrobial activity", AMINO ACIDS, vol. 13, pages 155 - 161 * |
彭小三 等: "甘氨酰组氨酰赖氨酸(GHK)的液相合成及其酶促降解", 中国生物化学与分子生物学报, vol. 19, no. 3, pages 406 - 409 * |
韩月 等: "胸腺五肽及其聚乙二醇衍生物的固相合成", 承德医学院学报, vol. 28, no. 4, pages 351 - 353 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116637209A (zh) * | 2023-05-18 | 2023-08-25 | 南京溯远基因科技有限公司 | 一种荧光染料复合物及其制备方法 |
CN116637209B (zh) * | 2023-05-18 | 2024-06-07 | 南京溯远基因科技有限公司 | 一种荧光染料复合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN113801190B (zh) | 2023-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017114191A9 (zh) | 索玛鲁肽的制备方法 | |
CN110835365B (zh) | 一种普卡那肽的制备方法 | |
CN110317188B (zh) | 化合物及其制备方法和应用 | |
CN112111001B (zh) | 胸腺肽Tα-1的合成方法 | |
CN107056894B (zh) | 一种片段法固相合成醋酸加尼瑞克的方法 | |
WO2021070202A1 (en) | A method for preparing glp-1 analogue by solid-phase peptide synthesis | |
CN113801190A (zh) | 寡肽-1盐酸盐的制备方法 | |
CN109096388A (zh) | 一种特立帕肽的制备方法 | |
JP2022527041A (ja) | プレカナチドを製造する改善された方法 | |
CN109988213B (zh) | 一种用于多肽液相合成载体的化合物及其制备方法和用途 | |
CN111944038A (zh) | 一种索玛鲁肽的合成方法 | |
CN113549130B (zh) | 一种丰胸肽的液相合成方法 | |
CN111233980B (zh) | 一种戈舍瑞林的片段法合成方法 | |
CN111393508B (zh) | 一种阿托西班的制备方法 | |
CN109988062B (zh) | 一种液相球形载体及其制备方法和应用 | |
WO2021007703A1 (en) | A method for preparing liraglutide via a solid phase peptide synthesis | |
CN112321699A (zh) | 一种司美格鲁肽的合成方法 | |
CN110386964B (zh) | 一种亮丙瑞林的固液合成方法 | |
CN108218980B (zh) | 一种胸腺法新的合成方法 | |
CN109293736B (zh) | 一种用于合成瑞林类药物的二肽 | |
WO2021007701A1 (en) | A method for preparing liraglutide via a solid phase peptide synthesis | |
CN112279891A (zh) | 一种改进的曲普瑞林的固相合成方法 | |
CN111944037A (zh) | 一种索玛鲁肽的合成方法 | |
CN116730902B (zh) | 一种合成利拉鲁肽的方法 | |
CN110191892A (zh) | 丙氨酸-赖氨酸-谷氨酸三肽衍生物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 518000 floor 3, building 2, Shenzhen biological incubation base, No. 10, Gaoxin Zhongyi Road, Maling community, Yuehai street, Nanshan District, Shenzhen, Guangdong Applicant after: SHENZHEN READLINE BIOTECHNOLOGY Co.,Ltd. Address before: 518054 Room 101, 1st floor, building 2, Shenzhen biological incubation base, No.10, Gaoxin middle 1st Road, Maling community, Yuehai street, Nanshan District, Shenzhen City, Guangdong Province Applicant before: SHENZHEN READLINE BIOTECHNOLOGY Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240419 Address after: 518000 floor 3, building 2, Shenzhen biological incubation base, No. 10, Gaoxin Zhongyi Road, Maling community, Yuehai street, Nanshan District, Shenzhen, Guangdong Patentee after: SHENZHEN READLINE BIOTECHNOLOGY Co.,Ltd. Country or region after: China Patentee after: Gansu ruidilin biological Co.,Ltd. Address before: 518000 floor 3, building 2, Shenzhen biological incubation base, No. 10, Gaoxin Zhongyi Road, Maling community, Yuehai street, Nanshan District, Shenzhen, Guangdong Patentee before: SHENZHEN READLINE BIOTECHNOLOGY Co.,Ltd. Country or region before: China |